Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor

Synapse

Volumn 66, Issue 7, 2012, Pages 630-639

  Fujimoto, Michiko ^a   Hayashi, Teruo ^a   Urfer, Roman ^b   Mita, Shiro ^b   Su, Tsung Ping ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b M's Science Corporation   (Japan)

Author keywords

Antidepressant; BDNF; Cleavage; Cutamesine; Depression; GDNF; Neuroprotection; SA4503; Secretion; Sigma receptor; Sigma 1 receptor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHAPERONE; CITRATE SYNTHASE; CUTAMESINE; GLUCOSE REGULATED PROTEIN 78; MESSENGER RNA; NEURITE PROMOTING FACTOR; NEUROTROPHIN; SIGMA 1 OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CRICETINAE; ENDOPLASMIC RETICULUM; LIGANDS; MOLECULAR CHAPERONES; NERVE GROWTH FACTORS; NEUROBLASTOMA; OLIGOPEPTIDES; PIPERAZINES; RATS; RECEPTORS, SIGMA; UP-REGULATION;

EID: 84860889919     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21549     Document Type: Article

References (39)

1. Aydar E, Palmer CP, Klyachko VA, Jackson MB. 2002. The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34: 399-410.
2. Baj G, Tongiorgi E. 2009. BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress. J Cell Sci 122: 36-43.
3. Brunoni AR, Lopes M, Fregni F. 2008. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11: 1169-1180.
4. Calabrese F, Molteni R, Cattaneo A, Macchi F, Racagni G, et al. 2010. Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Mol Pharmacol 77: 846-853.
5. Donnici L, Tiraboschi E, Tardito D, Musazzi L, Racagni G, Popoli M. 2008. Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells. BMC Neurosci 9: 61.
6. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. 1996. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381: 706-709.
7. Garzon DJ, Fahnestock M. 2007. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27: 2628-2635
8. Ghitza UE, Zhai H, Wu P, Airavaara M, Shaham Y, Lu L. 2010. Role of BDNF and GDNF in drug reward and relapse: A review. Neurosci Biobehav Rev 35: 157-171.
9. Hayashi T, Su TP. 2001. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci USA 98: 491-496.
10. Hayashi T, Su TP. 2007. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131: 596-610.
11. Hayashi T, Tsai SY, Mori T, Fujimoto M, Su TP. 2011. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 15: 557-577.
12. Katz JL, Su TP, Hiranita T, Hayashi T, Tanda G, et al. 2011. A role for sigma receptors in stimulant self administration and addiction. Pharmaceuticals (Basel) 4: 880-914.
13. Kikuchi-Utsumi K, Nakaki T. 2008. Chronic treatment with a selective ligand for the sigma-1 receptor chaperone, SA4503, up-regulates BDNF protein levels in the rat hippocampus. Neurosci Lett 440: 19-22.
14. Lee R, Kermani P, Teng KK, Hempstead BL. 2001. Regulation of cell survival by secreted proneurotrophins. Science 294: 1945-1948.
15. Lever JR, Gustafson JL, Xu R, Allmon RL, Lever SZ. 2006. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 59: 350-358.
16. Lou H, Kim SK, Zaitsev E, Snell CR, Lu B, Loh YP. 2005. Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase e. Neuron 45: 245-255.
17. Lu B. 2003. BDNF and activity-dependent synaptic modulation. Learn Mem 10: 86-98.
18. Lu B, Pang PT, Woo NH. 2005. The yin and yang of neurotrophin action. Nat Rev Neurosci 6: 603-614.
19. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, et al. 2001. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115: 1145-1153.
20. Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in depression and anxiety. Nat Neurosci 10: 1089-1093.
21. Matsumoto RR. 2009. Targeting sigma receptors: Novel medication development for drug abuse and addiction. Expert Rev Clin Pharmacol 2: 351-358.
22. Matsuno K, Kobayashi T, Tanaka MK, Mita S. 1996. Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol 312: 267-271.
23. Maurice T, Su TP. 2009. The pharmacology of sigma-1 receptors. Pharmacol Ther 124: 195-206.
24. Maurice T, Su TP, Privat A. 1998. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 83: 413-428.
25. Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, et al. 2010. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467: 59-63.
26. Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, et al. 2008. Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res 42: 1145-1153.
27. Penas C, Pascual-Font A, Mancuso R, Fores J, Casas C, Navarro X. 2011. Sigma receptor agonist 2-(4-morpholinethyl)1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes neuroprotection after root avulsion injury. J Neurotrauma 28: 831-840.
28. Racagni G, Popoli M. 2008. Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 10: 385-400.
29. Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH. 2010. Neurotrophic factor therapy for Parkinson's disease. Prog Brain Res 184: 237-264.
30. Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, et al. 2011. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 134: 732-746.
31. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, et al. 2003. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23: 349-357.
32. Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527-532.
33. Serres F, Carney SL. 2006. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor. Brain Res 1101: 36-42.
34. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, et al. 2003. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75.
35. Spruce BA, Campbell LA, McTavish N, Cooper MA, Appleyard MV, et al. 2004. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res 64: 4875-4886.
36. Su TP, London ED, Jaffe JH 1988. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune sytems. Science 240: 219-221.
37. Takebayashi M, Hayashi T, Su TP. 2002. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: Implications for antidepressants. J Pharmacol Exp Ther 303: 1227-1237.
38. Yagasaki Y, Numakawa T, Kumamaru E, Hayashi T, Su TP, Kunugi H. 2006. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem 281: 12941-12949.
39. Yasui-Furukori N, Tsuchimine S, Nakagami T, Fujii A, Sato Y, et al. 2011. Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder. Hum Psychopharmacol 26: 194-200.